MAQUET Cardiovascular has announced it has received FDA clearance for a new intra-aortic balloon catheter, according to a news release.
The SENSATION PLUS 7.5Fr. 40cc IAB catheter is designed to allow clinicians to provide IAB counterpulsation therapy to smaller patients – those who are 5'0" to 5'4" tall.
MAQUET also announced that the IAB catheter has received CE mark approval. It will be available for sale in the United States and European Union this month.
"Over the last 12 months, MAQUET has launched two new families of IAB catheters, as well as a new balloon pump, CARDIOSAVE — all of which are designed to revolutionize counterpulsation therapy, from both an efficacy and safety perspective," said Christian Keller, president and CEO of MAQUET Cardiovascular, in the release. "As a global leader in hemodynamic support, we are dedicated to developing and marketing new and innovative products that continuously improve the therapy needs of hemodynamically compromised patients thereby improving patient outcomes."
MAQUET is headquartered in Wayne, N.J.
Related Articles on FDA Clearances:
Providence Medical Technology Receives FDA Clearance for Bone Screws
Osseon Receives FDA Clearance for Steerable Inflatable Bone Tamp
SpineSmith Receives FDA Clearance for Plating System